Literature DB >> 21968922

Biochemical reconstitution of steroid receptor•Hsp90 protein complexes and reactivation of ligand binding.

Patrick J M Murphy1, Hannah R Franklin, Nathan W Furukawa.   

Abstract

Hsp90 is an essential and highly abundant molecular chaperone protein that has been found to regulate more than 150 eukaryotic signaling proteins, including transcription factors (e.g. nuclear receptors, p53) and protein kinases (e.g. Src, Raf, Akt kinase) involved in cell cycling, tumorigenesis, apoptosis, and multiple eukaryotic signaling pathways (1,2). Of these many 'client' proteins for hsp90, the assembly of steroid receptor•hsp90 complexes is the best defined (Figure 1). We present here an adaptable glucocorticoid receptor (GR) immunoprecipitation assay and in vitro GRhsp90 reconstitution method that may be readily used to probe eukaryotic hsp90 functional activity, hsp90-mediated steroid receptor ligand binding, and molecular chaperone cofactor requirements. For example, this assay can be used to test hsp90 cofactor requirements and the effects of adding exogenous compounds to the reconstitution process. The GR has been a particularly useful system for studying hsp90 because the receptor must be bound to hsp90 to have an open ligand binding cleft that is accessible to steroid (3). Endogenous, unliganded GR is present in the cytoplasm of mammalian cells noncovalently bound to hsp90. As found in the endogenous GRhsp90 heterocomplex, the GR ligand binding cleft is open and capable of binding steroid. If hsp90 dissociates from the GR or if its function is inhibited, the receptor is unable to bind steroid and requires reconstitution of the GRhsp90 heterocomplex before steroid binding activity is restored (4) . GR can be immunoprecipitated from cell cytosol using a monoclonal antibody, and proteins such as hsp90 complexed to the GR can be assayed by western blot. Steroid binding activity of the immunoprecipitated GR can be determined by incubating the immunopellet with [(3)H]steroid. Previous experiments have shown hsp90-mediated opening of the GR ligand binding cleft requires hsp70, a second molecular chaperone also essential for eukaryotic cell viability. Biochemical activity of hsp90 and hsp70 are catalyzed by co-chaperone proteins Hop, hsp40, and p23 (5). A multiprotein chaperone machinery containing hsp90, hsp70, Hop, and hsp40 are endogenously present in eukaryotic cell cytoplasm, and reticulocyte lysate provides a chaperone-rich protein source (6). In the method presented, GR is immunoadsorbed from cell cytosol and stripped of the endogenous hsp90/hsp70 chaperone machinery using mild salt conditions. The salt-stripped GR is then incubated with reticulocyte lysate, ATP, and K(+), which results in the reconstitution of the GRhsp90 heterocomplex and reactivation of steroid binding activity (7). This method can be utilized to test the effects of various chaperone cofactors, novel proteins, and experimental hsp90 or GR inhibitors in order to determine their functional significance on hsp90-mediated steroid binding (8-11).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968922      PMCID: PMC3230214          DOI: 10.3791/3059

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

Review 1.  Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.

Authors:  William B Pratt; David O Toft
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

2.  The Hsp organizer protein hop enhances the rate of but is not essential for glucocorticoid receptor folding by the multiprotein Hsp90-based chaperone system.

Authors:  Y Morishima; K C Kanelakis; A M Silverstein; K D Dittmar; L Estrada; W B Pratt
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 3.  Steroid receptor interactions with heat shock protein and immunophilin chaperones.

Authors:  W B Pratt; D O Toft
Journal:  Endocr Rev       Date:  1997-06       Impact factor: 19.871

4.  Stoichiometry, abundance, and functional significance of the hsp90/hsp70-based multiprotein chaperone machinery in reticulocyte lysate.

Authors:  P J Murphy; K C Kanelakis; M D Galigniana; Y Morishima; W B Pratt
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

5.  Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90.p60.hsp70-dependent step is sufficient for creating the steroid binding conformation.

Authors:  K D Dittmar; W B Pratt
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

6.  Identification of phosphorylated sites in the mouse glucocorticoid receptor.

Authors:  J E Bodwell; E Ortí; J M Coull; D J Pappin; L I Smith; F Swift
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Reconstitution of the steroid receptor.hsp90 heterocomplex assembly system of rabbit reticulocyte lysate.

Authors:  K D Dittmar; K A Hutchison; J K Owens-Grillo; W B Pratt
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

8.  Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket.

Authors:  Y Morishima; P J Murphy; D P Li; E R Sanchez; W B Pratt
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

9.  Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation.

Authors:  Patrick J M Murphy; Mario D Galigniana; Yoshihiro Morishima; Jennifer M Harrell; Roland P S Kwok; Mats Ljungman; William B Pratt
Journal:  J Biol Chem       Date:  2004-05-15       Impact factor: 5.157

10.  Visualization and mechanism of assembly of a glucocorticoid receptor.Hsp70 complex that is primed for subsequent Hsp90-dependent opening of the steroid binding cleft.

Authors:  Patrick J M Murphy; Yoshihiro Morishima; Haifeng Chen; Mario D Galigniana; John F Mansfield; S Stoney Simons; William B Pratt
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.